news
09-13-2018, 09:57 PM
https://i.cbc.ca/1.4822074.1536854095!/fileImage/httpImage/image.jpg_gen/derivatives/16x9_460/blood-pressure-cuff.jpg A second impurity that is a classified as a probable human carcinogen has been found in valsartan, manufactured by Zhejiang Huahai Pharmaceuticals in China, Health Canada announces.
More... (https://start.westnet.ca/newstempcb.php?article=health/valsartan-impurity-ndea-1.4822062)
From http://start.westnet.ca News
News Provided By
WestNet Wireless Internet
More... (https://start.westnet.ca/newstempcb.php?article=health/valsartan-impurity-ndea-1.4822062)
From http://start.westnet.ca News
News Provided By
WestNet Wireless Internet